Are Allergy Drops Side Effects Normal? What to Expect

Yes, an itchy or tingling mouth is the single most common and most normal reaction to sublingual allergy drops. Because the allergen extract is held under the tongue, it contacts the oral lining directly, which often produces mild itching of the lips, tongue, mouth, throat, or ears within minutes of a dose. Research shows local reactions like this affect roughly 40.8% of users, and they are usually mild and short-lived. In most people the itching eases over the first one to two weeks as the immune system builds tolerance. It is a sign the treatment is engaging, not a sign of harm. That said, drops are not free of side effects, so if the itching becomes severe, spreads, or is joined by swelling or breathing trouble, stop and contact your provider.

Normal local side effects from allergy drops are typically brief, often lasting only minutes to a few hours after each dose during the early phase of treatment. Across the first one to two weeks, most people notice these reactions gradually become milder and less frequent as their immune system adapts to the allergen. By the time you reach a steady maintenance dose, many users have few or no noticeable local effects. If a reaction lasts well beyond a few hours, recurs strongly every dose without easing over several weeks, or worsens over time, that falls outside the normal pattern and is worth reporting to your provider. Anything systemic, such as breathing difficulty or widespread hives, is never considered normal and needs urgent attention.

A reaction is not normal when it is systemic rather than local, when local swelling is pronounced, or when symptoms worsen instead of easing over the first weeks. Warning signs that fall outside the expected mild pattern include difficulty breathing, throat tightness, widespread hives, swelling beyond the mouth, dizziness, or fainting. These systemic reactions are exceptionally rare, occurring in fewer than 0.1% of patients in our program, with anaphylaxis estimated at roughly one per 100 million doses and no fatalities reported worldwide, but they are medical concerns when they happen. If you experience any of them, use your prescribed epinephrine auto-injector if instructed and seek emergency care. Persistent or severe local reactions that do not settle should also prompt a call to your provider for a dose review.

Mild local reactions are a reasonable sign that the treatment is engaging your immune system, but they are not a reliable measure of how well the drops will work for you. The presence or absence of mouth itching does not predict whether you will achieve meaningful symptom relief over the longer course of treatment. Some people experience clear local reactions and respond well; others have minimal reactions and still benefit. Immunotherapy works gradually, and durable benefit generally requires several years of consistent use, so the early local effects simply reflect direct allergen contact with the oral lining. Rather than reading too much into side effects, track your seasonal or year-round symptoms over months with your provider, who can judge whether the treatment is producing the intended improvement.

Usually no. Mild, expected local reactions such as mouth or throat itching are not a reason to stop sublingual immunotherapy, because they typically ease on their own as tolerance builds over the first weeks. Stopping at the first sign of normal side effects can interrupt the gradual desensitization the treatment depends on. The situation is different for reactions outside the normal range: pronounced or persistent local swelling warrants a call to your provider, who may adjust your dose, and any systemic symptoms such as breathing difficulty or widespread hives mean you should stop, use prescribed epinephrine if instructed, and seek emergency care. When in doubt, contact your care team before deciding to stop, since they can distinguish a normal adjustment reaction from a genuine problem.